Millipore Sigma Vibrant Logo

658550 AG 1295 - CAS 71897-07-9 - Calbiochem

A cell-permeable, reversible, ATP-competitive, and selective inhibitor of platelet-derived growth factor (PDGF) receptor kinase (IC₅₀ = 500 nM) and PDGF-dependent DNA synthesis (IC₅₀ = 2.5 µM) in Swiss/3T3 cells.

AG 1295 - CAS 71897-07-9 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: 6,7-Dimethyl-2-phenylquinoxaline

Primary Target: PDGFR kinase
View Products on Sigmaaldrich.com
658550
View Pricing & Availability

Overview

Replacement Information

Key Spec Table

CAS #Empirical Formula
71897-07-9C₁₆H₁₄N₂

Pricing & Availability

Catalogue Number AvailabilityPackaging Qty/Pack Price Quantity
658550-5MG
Retrieving availability...
—
Fulfillment and Delivery Delayed Fulfillment and Delivery Delayed
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      		 Plastic ampoule 5 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      —
      Request Pricing
      		 —
      Description
      OverviewA cell-permeable, reversible, ATP-competitive, and selective inhibitor of platelet-derived growth factor (PDGF) receptor kinase (IC50 = 500 nM) and PDGF-dependent DNA synthesis (IC50 = 2.5 µM) in Swiss/3T3 cells. Has no effect on EGF receptor autophosphorylation and shows only a weak effect on EGF- or insulin-stimulated DNA synthesis. A potent blocker of smooth muscle cell proliferation.
      Catalogue Number658550
      Brand Family Calbiochem®
      Synonyms6,7-Dimethyl-2-phenylquinoxaline
      References
      ReferencesBanai, S., et al. 1998. Circulation 97, 1960.
      Levitzki, A., and Gazit, A. 1995. Science 267, 1782.
      Kovalenko, M., et al. 1994. Cancer Res. 54, 6106.
      Product Information
      CAS number71897-07-9
      ATP CompetitiveY
      FormWhite to yellow solid
      Hill FormulaC₁₆H₁₄N₂
      Chemical formulaC₁₆H₁₄N₂
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetPDGFR kinase
      Primary Target IC<sub>50</sub>500 nM against PDGFR kinase
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      658550-5MG 07790788052225

      Documentation

      AG 1295 - CAS 71897-07-9 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      AG 1295 - CAS 71897-07-9 - Calbiochem Certificates of Analysis

      TitleLot Number
      658550

      References

      Reference overview
      Banai, S., et al. 1998. Circulation 97, 1960.
      Levitzki, A., and Gazit, A. 1995. Science 267, 1782.
      Kovalenko, M., et al. 1994. Cancer Res. 54, 6106.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision03-September-2020 JSW
      Synonyms6,7-Dimethyl-2-phenylquinoxaline
      DescriptionSelectively inhibits platelet-derived growth factor (PDGF) receptor kinase (IC50 = 500 nM) and the PDGF-dependent DNA synthesis (IC50 = 2.5 µM) in Swiss 3T3 cells. Has no effect on epidermal growth factor (EGF) receptor autophosphorylation and shows only a weak effect on EGF- or insulin-stimulated DNA synthesis.
      FormWhite to yellow solid
      CAS number71897-07-9
      Chemical formulaC₁₆H₁₄N₂
      Structure formulaStructure formula
      Purity≥95% by HPLC
      SolubilityDMSO (10 mg/ml) or CH₂Cl₂
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
      Toxicity Standard Handling
      ReferencesBanai, S., et al. 1998. Circulation 97, 1960.
      Levitzki, A., and Gazit, A. 1995. Science 267, 1782.
      Kovalenko, M., et al. 1994. Cancer Res. 54, 6106.